Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
Selinexor is used together with bortezomib and dexamethasone to treat multiple myeloma in patients who have received at least 1 previous treatment that did not work well. It is also used together with dexamethasone to treat multiple myeloma that has come back (relapsed) or has not responded to treatment (refractory) in patients who have received at least 4 previous treatments that did not work well and cannot be treated with certain cancer medicines (eg, at least 2 proteosome inhibitors, at least 2 immunomodulatory agents, and an anti-CD38 monoclonal antibody).
Selinexor is also used to treat certain types of diffuse large B-cell lymphoma (DLBCL) that has come back or has not responded to treatment (eg, DLBCL arising from follicular lymphoma) in patients who have received at least 2 previous treatments given by mouth or injection.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2023
Copyright: © Merative US L.P. 1973, 2023. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.